BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30224918)

  • 1. Interplay between Body Size Measures and Thyroid Cancer Aggressiveness: A Retrospective Analysis.
    de Melo TG; da Assumpção LVM; Zantut-Wittmann DE
    Int J Endocrinol; 2018; 2018():2089471. PubMed ID: 30224918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and risk of differentiated thyroid cancer: A large-scale case-control study.
    He Q; Sun H; Li F; Liang N
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):869-878. PubMed ID: 31479527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices.
    Trésallet C; Seman M; Tissier F; Buffet C; Lupinacci RM; Vuarnesson H; Leenhardt L; Menegaux F
    Surgery; 2014 Nov; 156(5):1145-52. PubMed ID: 24878452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are Higher Body Mass Index and Worse Metabolic Parameters Associated with More Aggressive Differentiated Thyroid Cancer? A Retrospective Cohort Study.
    Abu Arar Y; Shilo M; Bilenko N; Friger M; Marsha H; Fisher D; Fraenkel M; Yoel U
    Healthcare (Basel); 2024 Mar; 12(5):. PubMed ID: 38470692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.
    Gąsior-Perczak D; Pałyga I; Szymonek M; Kowalik A; Walczyk A; Kopczyński J; Lizis-Kolus K; Trybek T; Mikina E; Szyska-Skrobot D; Gadawska-Juszczyk K; Hurej S; Szczodry A; Słuszniak A; Słuszniak J; Mężyk R; Góźdź S; Kowalska A
    PLoS One; 2018; 13(10):e0204668. PubMed ID: 30273371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Body Mass Index and Body Surface Area on the Behavior of Papillary Thyroid Carcinoma.
    Kim SK; Woo JW; Park I; Lee JH; Choe JH; Kim JH; Kim JS
    Thyroid; 2016 May; 26(5):657-66. PubMed ID: 26959390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonanaplastic follicular cell-derived thyroid carcinoma: mitosis and necrosis in long-term follow-up.
    Skansing DB; Londero SC; Asschenfeldt P; Larsen SR; Godballe C
    Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2541-2548. PubMed ID: 28293786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer.
    Kim HJ; Kim NK; Choi JH; Sohn SY; Kim SW; Jin SM; Jang HW; Suh S; Min YK; Chung JH; Kim SW
    Clin Endocrinol (Oxf); 2013 Jan; 78(1):134-40. PubMed ID: 22812676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poorly differentiated thyroid carcinoma and poorly differentiated area in differentiated thyroid carcinoma: is there any difference?
    Bichoo RA; Mishra A; Kumari N; Krishnani N; Chand G; Agarwal G; Agarwal A; Mishra SK
    Langenbecks Arch Surg; 2019 Feb; 404(1):45-53. PubMed ID: 30673845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Postoperative Stimulated Thyroglobulin as Prognostic Factor for Differentiated Thyroid Cancer in Children and Adolescents.
    Zanella A; Scheffel RS; Pasa MW; Dora JM; Maia AL
    Thyroid; 2017 Jun; 27(6):787-792. PubMed ID: 28292215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Tumor Size and Minimal Extrathyroidal Extension in Patients with Differentiated Thyroid Cancer.
    Tam S; Amit M; Boonsripitayanon M; Busaidy NL; Cabanillas ME; Waguespack SG; Gross ND; Grubbs EG; Williams MD; Lai SY; Sturgis EM; Zafereo ME
    Thyroid; 2018 Aug; 28(8):982-990. PubMed ID: 29936892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric differentiated thyroid carcinoma: The clinicopathological features and the coexistence of Hashimoto's thyroiditis.
    Ren PY; Liu J; Xue S; Chen G
    Asian J Surg; 2019 Jan; 42(1):112-119. PubMed ID: 29254871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease Burden and Outcome in Children and Young Adults With Concurrent Graves Disease and Differentiated Thyroid Carcinoma.
    MacFarland SP; Bauer AJ; Adzick NS; Surrey LF; Noyes J; Kazahaya K; Mostoufi-Moab S
    J Clin Endocrinol Metab; 2018 Aug; 103(8):2918-2925. PubMed ID: 29788090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question.
    Elisei R; Molinaro E; Agate L; Bottici V; Masserini L; Ceccarelli C; Lippi F; Grasso L; Basolo F; Bevilacqua G; Miccoli P; Di Coscio G; Vitti P; Pacini F; Pinchera A
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1516-27. PubMed ID: 20156922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor size interpretation for predicting cervical lymph node metastasis using a differentiated thyroid cancer risk model.
    Shi RL; Qu N; Yang SW; Ma B; Lu ZW; Wen D; Sun GH; Wang Y; Ji QH
    Onco Targets Ther; 2016; 9():5015-22. PubMed ID: 27574443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
    Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
    Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association between obesity and aggressiveness of differentiated thyroid cancer.
    Grani G; Lamartina L; Montesano T; Ronga G; Maggisano V; Falcone R; Ramundo V; Giacomelli L; Durante C; Russo D; Maranghi M
    J Endocrinol Invest; 2019 Jan; 42(1):85-90. PubMed ID: 29667113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.
    Choi JB; Lee SG; Kim MJ; Kim TH; Ban EJ; Lee CR; Lee J; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
    Head Neck; 2019 Jan; 41(1):56-63. PubMed ID: 30536465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease Severity at Presentation in Patients with Disease-Related Mortality from Differentiated Thyroid Cancer: Implications for the 2015 ATA Guidelines.
    Robenshtok E; Nachalon Y; Benbassat C; Hirsch D; Shimon I; Grossman A; Diker-Cohen T; Akirov A; Popovtzer A
    Thyroid; 2017 Sep; 27(9):1171-1176. PubMed ID: 28791923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gender-related clinical characteristics in patients with differentiated thyroid cancers].
    Yan H; Gu W; Lyu Z; Yang G; Ba J; Wang X; Ouyang J; Guo Q; Du J; Jin N; Zang L; Dou J; Mu Y
    Zhonghua Nei Ke Za Zhi; 2014 Apr; 53(4):286-9. PubMed ID: 24857302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.